Key facts
- AEMS’s last known valuation is $750K (Aug 2020).
- It has raised $1.1M; the latest was Later Stage VC ($330K) in Mar 2026.
- Notable investors include Colorado Venture Capital Authority, Daybreak Labs, U.S. Department of Health and Human Services.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for AEMS
- ·The full record, as it builds
Funding rounds
No funding rounds for AEMS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AEMS
Developer of chemical materials designed to improve the accessibility, safety, and sustainability of nutritious food. The company develops protective chemicals made with organic, food-safe active ingredients and natural supportive ingredients to offer rapid development to problems affecting the entire food supply chain, enabling farmers to get authentic crop protection to improve crop health naturally.
- Sector
- Materials and Resources
- HQ
- Denver, CO, United States
- Founded
- 2019
- Employees
- 7
- Website
- aemscorp.com/
- Ownership
- Privately Held (backing)
AEMS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AEMS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AEMS in its N-PORT filings yet. We sweep new filings monthly.